ArticleACS medicinal chemistry letters2019

Discovery of ABBV/GLPG-3221, a Potent Corrector of CFTR for the Treatment of Cystic Fibrosis.

Marc J C Scanio et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.